This study provides novel mechanistic insights into pathogenesis of HFD-induced inflammation and indicates that PSPC is a candidate for pharmacological intervention of obesity-related metabolic diseases. This evidence concerns the gene SFTPC and obesity due to melanocortin 4 receptor deficiency.